{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:02:20Z","timestamp":1789390940370,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05114-x","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:03:00Z","timestamp":1782356580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of prophylactic administration of new-generation antiepileptic drugs for prevention of seizures following surgical clipping in patients with aneurysmal subarachnoid hemorrhage"],"prefix":"10.1186","volume":"26","author":[{"given":"Tomomichi","family":"Kayahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokyo","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Take","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5114_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12028-018-0506-z","volume":"29","author":"BB Allen","year":"2018","unstructured":"Allen BB, Forgacs PB, Fakhar MA, Wu X, Gerber LM, Boddu S, Murthy SB, Stieg PE, Mangat HS. Association of seizure occurrence with aneurysm treatment modality in aneurysmal subarachnoid hemorrhage patients. Neurocrit Care. 2018;29:62\u20138.","journal-title":"Neurocrit Care"},{"issue":"2","key":"5114_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1756285616675777","volume":"10","author":"S Bauer","year":"2017","unstructured":"Bauer S, Willems LM, Paule E, Petschow C, Z\u00f6llner JP, Rosenow F, Strzelczyk A. The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience. Ther Adv Neurol Disord. 2017;10(2):103\u201326.","journal-title":"Ther Adv Neurol Disord"},{"key":"5114_CR3","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","volume":"48","author":"E Ben-Menachem","year":"2007","unstructured":"Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia. 2007;48:1308\u201317.","journal-title":"Epilepsia"},{"key":"5114_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1212\/01.WNL.0000038906.71394.DE","volume":"60","author":"J Claassen","year":"2003","unstructured":"Claassen J, Peery S, Kreiter KT, Hirsch LJ, Du EY, Connolly ES, Mayer SA. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 2003;60:208\u201314.","journal-title":"Neurology"},{"key":"5114_CR5","doi-asserted-by":"publisher","first-page":"120519","DOI":"10.1016\/j.jns.2022.120519","volume":"444","author":"M Darkwah Oppong","year":"2023","unstructured":"Darkwah Oppong M, Lohrer L, Wrede KH, Chihi M, Santos AN, Dammann P, Michel A, Rauschenbach L, Said M, Li Y, Frank B, Sure U, Jabbarli R. Reevaluation of risk factors for aneurysmal subarachnoid hemorrhage associated epilepsy. J Neurol Sci. 2023;444:120519.","journal-title":"J Neurol Sci"},{"key":"5114_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000002281","volume":"86","author":"GM De Marchis","year":"2016","unstructured":"De Marchis GM, Pugin D, Meyers E, Velasquez A, Suwatcharangkoon S, Park S, Falo MC, Agarwal S, Mayer S, Schmidt JM, Connolly ES. Claassen J.Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. 2016;86:253\u201360.","journal-title":"Neurology"},{"key":"5114_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1017\/cjn.2019.54","volume":"46","author":"AA Dmytriw","year":"2019","unstructured":"Dmytriw AA, Maragkos GA, Zuccato J, Singh JM, Wilcox ME, Schweikert S. Use of antiepileptic drugs in aneurysmal subarachnoid hemorrhage. Can J Neurol Sci. 2019;46:423\u20139.","journal-title":"Can J Neurol Sci"},{"key":"5114_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mol.107.039867","volume":"73","author":"AC Errington","year":"2008","unstructured":"Errington AC, St\u00f6hr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73:157\u201369.","journal-title":"Mol Pharmacol"},{"key":"5114_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12028-021-01296-z","volume":"36","author":"T Fang","year":"2022","unstructured":"Fang T, Valdes E, Frontera JA. Levetiracetam for seizure prophylaxis in neurocritical care: A systematic review and meta-analysis. Neurocrit Care. 2022;36:248\u201358.","journal-title":"Neurocrit Care"},{"key":"5114_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","volume":"54","author":"B Farrell","year":"1991","unstructured":"Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044\u201354.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5114_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","volume":"52","author":"T Hanada","year":"2011","unstructured":"Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y. Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia. 2011;52:1331\u201340.","journal-title":"Epilepsia"},{"key":"5114_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12975-021-00934-0","volume":"13","author":"F Kawakita","year":"2022","unstructured":"Kawakita F, Kanamaru H, Asada R, Imanaka-Yoshida K, Yoshida T, Suzuki H. Inhibition of AMPA (\u03b1-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptor reduces acute blood-brain barrier disruption after subarachnoid hemorrhage in mice. Transl Stroke Res. 2022;13:326\u201337.","journal-title":"Transl Stroke Res"},{"issue":"18","key":"5114_CR13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","volume":"78","author":"GL Krauss","year":"2012","unstructured":"Krauss GL, Serratosa JM, Villanueva V, Endziniene M, Hong Z, French J, Yang H, Squillacote D, Edwards HB, Zhu J, Laurenza A. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology. 2012;78(18):1408\u201315.","journal-title":"Neurology"},{"key":"5114_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12028-011-9584-x","volume":"15","author":"G Lanzino","year":"2011","unstructured":"Lanzino G, D\u2019Urso PI, Suarez J, Diringer MN, Bleck TP, Bruder N, Connolly ES, Citerio G, Gress D, Hanggi D, Hemphill JC, Hoh B, Lanzino G, Le Roux P, Menon D, Rabinstein A, Schmutzhard E, Shutter L, Stocchetti N, Suarez J, Treggiari M, Tseng MY, Vergouwen M, Vespa P, Wolf S, Zipfel GJ. Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15:247\u201356.","journal-title":"Neurocrit Care"},{"key":"5114_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1017\/cjn.2017.206","volume":"44","author":"SH Mahmoud","year":"2017","unstructured":"Mahmoud SH, Buxton J. Seizures and choice of antiepileptic drugs following subarachnoid hemorrhage: A review. Can J Neurol Sci. 2017;44:643\u201353.","journal-title":"Can J Neurol Sci"},{"key":"5114_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.STR.0000141936.36596.1e","volume":"36","author":"AM Naidech","year":"2005","unstructured":"Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36:583\u20137.","journal-title":"Stroke"},{"key":"5114_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2176\/jns-nmc.2023-0201","volume":"64","author":"S Nakashima","year":"2024","unstructured":"Nakashima S, Nishibayashi H, Yako R, Ishii M, Toki N, Tomobuchi M, Nakai T, Yamoto H, Nakanishi Y. Nakao N.) Factors associated with early and late seizure related to aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2024;64:123\u201330.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"5114_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yebeh.2018.03.029","volume":"83","author":"JE Pi\u00f1a-Garza","year":"2018","unstructured":"Pi\u00f1a-Garza JE, Lagae L, Villanueva V, Renfroe JB, Laurenza A, Williams B, Kumar D, Meador KJ. Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures. Epilepsy Behav. 2018;83:50\u20138.","journal-title":"Epilepsy Behav"},{"key":"5114_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.wneu.2012.08.006","volume":"79","author":"DM Raper","year":"2013","unstructured":"Raper DM, Starke RM, Komotar RJ, Allan R, Connolly ES. Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg. 2013;79:682\u201390.","journal-title":"World Neurosurg"},{"key":"5114_CR20","doi-asserted-by":"crossref","unstructured":"Rogawski MA. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl. 2013;(197):9\u201318.","DOI":"10.1111\/ane.12099"},{"key":"5114_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s12975-022-01101-9","volume":"14","author":"H Suzuki","year":"2023","unstructured":"Suzuki H, Miura Y, Yasuda R, Yago T, Mizutani H, Ichikawa T, Miyazaki T, Kitano Y, Nishikawa H, Kawakita F, Fujimoto M, Toma N. Effects of new-generation antiepileptic drug prophylaxis on delayed neurovascular events after aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 2023;14:899\u2013909.","journal-title":"Transl Stroke Res"},{"key":"5114_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuint.2017.02.002","volume":"107","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Ihara M. Post-stroke epilepsy. Neurochem Int. 2017;107:219\u201328.","journal-title":"Neurochem Int"},{"key":"5114_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604\u20137.","journal-title":"Stroke"},{"key":"5114_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fneur.2013.00192","volume":"4","author":"C Wright","year":"2013","unstructured":"Wright C, Downing J, Mungall D, Khan O, Williams A, Fonkem E, Garrett D, Aceves J, Kirmani B. Clinical pharmacology and pharmacokinetics of levetiracetam. Front Neurol. 2013;4:192.","journal-title":"Front Neurol"},{"key":"5114_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0306-4522(99)00392-9","volume":"94","author":"K Zilles","year":"1999","unstructured":"Zilles K, Q\u00fc MS, K\u00f6hling R, Speckmann EJ. Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography. Neuroscience. 1999;94:1051\u201361.","journal-title":"Neuroscience"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05114-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:02:17Z","timestamp":1789387337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05114-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5114"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05114-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Institutional Review Board of Saitama Medical University International Medical Center (IRB No. 2025-007). This study was deemed exempt from the need to obtain patient consent by the Institutional Review Board. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave written informed consent for their personal or clinical details along with any identifying images to be published in this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"577"}}